In which year will a person with 10M+ Instagram followers undergo gene therapy?

This is a New Scientist news report about Minicircle preparing to sell an unapproved longevity gene therapy via international partner clinics after a small proof-of-concept trial. It bears on the forecast because expanding commercial availability of elective gene therapy could make a publicly documented treatment by a celebrity or influencer with 10M+ Instagram followers more plausible before 2035.

This is a mainstream news report from MIT Technology Review about Unlimited Bio planning near-term human injections of experimental gene therapies for enhancement/longevity-related uses. It is not direct resolution evidence, but it is relevant background because it suggests gene-therapy procedures aimed at high-profile self-experimenters could become publicly documented within the prediction horizon.

This is a Nature news article reporting that the first person has been treated in a gene-therapy trial intended to rejuvenate damaged eye cells via cellular reprogramming. It is relevant because it is mainstream-news evidence that human gene-therapy use is expanding into high-visibility anti-ageing/rejuvenation applications, which bears on the timeline for a future celebrity-scale documented case.

This is a news article reporting that the FDA cleared Life Biosciences to begin a human study of a gene-therapy-based partial epigenetic reprogramming approach associated with David Sinclair. It bears on the prediction because it is evidence that anti-aging gene therapy is moving into human clinical testing, which affects the plausibility and timing of eventual public uptake by high-profile individuals.

This is a company blog post summarizing and contextualizing Bryan Johnson's reported gene therapy experience in early 2024, including that he documented it publicly. It does not establish the 10M+ Instagram-followers threshold, but it is relevant as precedent that a high-profile public figure has publicly discussed undergoing gene therapy.

This is a Rejuvenate Bio press release describing preclinical gene-therapy-mediated partial reprogramming results and linking them to a journal publication. It is relevant because it is evidence of progress toward anti-aging gene therapies that could eventually be taken up by high-profile public figures, though it is not direct evidence of any human celebrity undergoing treatment.

This is a news-style article about the FDA clearing Life Biosciences' IND for ER-100, an epigenetic gene-therapy-like rejuvenation treatment, with initial human ocular trials beginning in 2026 and possible expansion to liver disease by 2027-2028. It bears on the prognosis indirectly by indicating when rejuvenation-oriented gene therapies may become credible and visible enough to later be adopted by high-profile public figures.

This is the homepage of a company marketing plasmid gene therapy for longevity, performance, and wellness, indicating that such interventions are being commercially offered outside conventional trials. It bears on the prognosis by showing real-world availability and promotion of gene therapy that could plausibly be adopted and publicly documented by high-profile influencers or celebrities.

This is an Instagram news post summarizing that early human trials are underway for an experimental gene therapy aimed at making aging cells function more like younger cells. It is relevant as background evidence that human anti-aging gene therapy is already entering clinical testing, which bears on when a highly followed public figure might plausibly undergo and publicize such a treatment.

This is a Fight Aging commentary discussing a human follistatin gene therapy trial/self-experiment, indicating that publicly discussed elective gene-therapy use already exists outside mainstream approved care. It bears on the forecast as a benchmark for how plausible it is that a high-profile public figure could later publicly document undergoing gene therapy.

This appears to be a news article about people publicly pursuing experimental gene therapy outside normal regulatory channels. It is relevant because it documents real-world, public-facing gene therapy self-experimentation, a precursor trend for eventual uptake by higher-profile social-media celebrities.